Founded in 2012, MapMyGenome operates in Health Tech industry. Initially focusing on preventive genomics and personal wellness assessments, the company has expanded its offerings to include nutrigenom...
Funding stage:
Seed
Last funding:
02/06/2015
Total funding:
$2.30 Mn+
Revenue:
Investors
Employee count:
128
Last 90d
128
Last 90d
Web traffic:
50.87K
50.87K
Last 30d
Last 30d
Glassdoor Rating:
MapMyGenome: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders28
Latest Filing Date30 March 2022- Funding Events20
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of MapMyGenome
As of 31 March 2022, MapMyGenome's equity is held by 28 shareholders, with the top three being Anu Acharya, Subash Lingareddy, and Ratan N Tata.
Anu Acharya holds the largest stake in MapMyGenome at 68.7% as of 31 March 2022.
As of 31 March 2022, founders collectively hold 74.8% equity in MapMyGenome.
As of 31 March 2022, investors collectively hold 19.7% equity in MapMyGenome.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links